amiodarone has been researched along with Thyroiditis in 22 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Thyroiditis: Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type 2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be unacceptable for patients with underlying cardiac disorders." | 9.12 | Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Dell'Unto, E; Martino, E; Rossi, G; Tanda, ML; Tomisti, L, 2007) |
| "Amiodarone (AMIO) is one of the most effective antiarrhythmic drugs available; however, its use is limited by a serious side effect profile, including thyroiditis." | 7.81 | Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis. ( Farenholtz, KE; Inabnet, WB; Lombardi, A; Owen, R; Tomer, Y, 2015) |
| "Type 2 amiodarone-induced thyrotoxicosis (AIT) is a destructive thyroiditis usually responsive to glucocorticoids; however, recent surveys showed that many expert thyroidologists worldwide use thionamides for type 2 AIT patients." | 7.75 | Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. ( Bartalena, L; Bogazzi, F; Dell'Unto, E; Martino, E; Pepe, P; Rossi, G; Tomisti, L, 2009) |
| "Amiodarone-induced thyrotoxicosis (AIT) type 1 occurs in subjects with an underlying thyroid disease, whereas type 2 AIT is a form of destructive thyroiditis." | 7.73 | Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations. ( Dietlein, M; Schicha, H, 2005) |
| "Optimal daily levothyroxine (LT4) dosage is reported to be significantly smaller in the elderly with primary hypothyroidism when compared with their younger counterparts." | 7.69 | Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology. ( Kabadi, UM, 1997) |
| "Amiodarone is an iodine-rich drug used in the treatment of resistant cardiac arrhythmias." | 5.29 | Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
| "Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type 2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be unacceptable for patients with underlying cardiac disorders." | 5.12 | Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Dell'Unto, E; Martino, E; Rossi, G; Tanda, ML; Tomisti, L, 2007) |
| "Type 2 amiodarone-induced thyrotoxicosis (AIT) is a destructive thyroiditis usually responsive to glucocorticoids; however, recent surveys showed that many expert thyroidologists worldwide use thionamides for type 2 AIT patients." | 3.75 | Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. ( Bartalena, L; Bogazzi, F; Dell'Unto, E; Martino, E; Pepe, P; Rossi, G; Tomisti, L, 2009) |
| "Amiodarone-induced thyrotoxicosis (AIT) type 1 occurs in subjects with an underlying thyroid disease, whereas type 2 AIT is a form of destructive thyroiditis." | 3.73 | Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations. ( Dietlein, M; Schicha, H, 2005) |
| " This study was intended to determine whether CRP levels could differentiate between inflammatory and noninflammatory thyroid conditions, especially between type II inflammatory amiodarone-induced thyrotoxicosis (AIT) and type I iodine-induced AIT." | 3.72 | The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. ( Bogazzi, F; Braverman, LE; Brogioni, S; Lazarus, JH; Martino, E; Pardini, E; Parkes, AB; Pearce, EN; Pellegrini, G; Pinchera, A, 2003) |
| "Optimal daily levothyroxine (LT4) dosage is reported to be significantly smaller in the elderly with primary hypothyroidism when compared with their younger counterparts." | 3.69 | Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology. ( Kabadi, UM, 1997) |
| "Amiodarone may cause amiodarone-induced hypothyroidism (AIH) or amiodarone-induced thyrotoxicosis (AIT)." | 2.82 | AMIODARONE AND THYROID DYSFUNCTION. ( Alfirević, M; Bakula, M; Marić, N; Medić, F; Mucić, K, 2022) |
| "Thyrotoxicosis is a common disorder, especially in women." | 2.48 | Thyrotoxicosis. ( Boelaert, K; Franklyn, JA, 2012) |
| "Amiodarone is an iodine-rich drug." | 2.42 | [Amiodarone and the thyroid gland]. ( Bednarek-Tupikowska, G; Bugajski, J; Filus, A; Kuliczkowska, J, 2004) |
| "Amiodarone is an iodine-rich drug used in the treatment of resistant cardiac arrhythmias." | 1.29 | Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. ( Bianconi, L; Braverman, LE; Gardini, E; Minelli, R; Roti, E, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Cappellani, D | 1 |
| Torregrossa, L | 1 |
| Papini, P | 1 |
| Poma, AM | 1 |
| Ambrosini, E | 1 |
| De Napoli, L | 1 |
| Materazzi, G | 1 |
| Basolo, F | 1 |
| Bogazzi, F | 4 |
| Medić, F | 1 |
| Bakula, M | 2 |
| Alfirević, M | 1 |
| Mucić, K | 1 |
| Marić, N | 1 |
| Lombardi, A | 1 |
| Inabnet, WB | 1 |
| Owen, R | 1 |
| Farenholtz, KE | 1 |
| Tomer, Y | 1 |
| Rizzo, LF | 1 |
| Mana, DL | 1 |
| Bruno, OD | 1 |
| Tomisti, L | 2 |
| Rossi, G | 2 |
| Dell'Unto, E | 2 |
| Pepe, P | 1 |
| Bartalena, L | 2 |
| Martino, E | 3 |
| Franklyn, JA | 1 |
| Boelaert, K | 1 |
| Mete, O | 1 |
| Asa, SL | 1 |
| Sniezek, JC | 1 |
| Francis, TB | 1 |
| Pearce, EN | 1 |
| Brogioni, S | 1 |
| Pardini, E | 1 |
| Pellegrini, G | 1 |
| Parkes, AB | 1 |
| Lazarus, JH | 1 |
| Pinchera, A | 1 |
| Braverman, LE | 2 |
| Bednarek-Tupikowska, G | 1 |
| Filus, A | 1 |
| Kuliczkowska, J | 1 |
| Bugajski, J | 1 |
| Dietlein, M | 1 |
| Schicha, H | 1 |
| Tanda, ML | 1 |
| Aghini-Lombardi, F | 1 |
| Blank, W | 1 |
| Braun, B | 1 |
| Léger, AF | 1 |
| Fragu, P | 1 |
| Rougier, P | 1 |
| Laurent, MF | 1 |
| Tubiana, M | 1 |
| Savoie, JC | 1 |
| Roti, E | 1 |
| Minelli, R | 1 |
| Gardini, E | 1 |
| Bianconi, L | 1 |
| Samaras, K | 1 |
| Marel, GM | 1 |
| Kabadi, UM | 1 |
| Ybarra, J | 1 |
| Fuster, D | 1 |
| Martín, F | 1 |
| Lomeña, F | 1 |
| Torregrossa, JV | 1 |
| Moreno-Reyes, R | 1 |
| Corvilain, B | 1 |
| Goichot, B | 1 |
| Grunenberger, F | 1 |
| Schlienger, JL | 1 |
| Himsworth, RL | 1 |
| Leung, WH | 1 |
| Pun, KK | 1 |
| Lau, CP | 1 |
| Wong, CK | 1 |
| Wang, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for amiodarone and Thyroiditis
| Article | Year |
|---|---|
AMIODARONE AND THYROID DYSFUNCTION.
Topics: Amiodarone; Humans; Hypothyroidism; Iodine; Thyroiditis; Thyrotoxicosis; Thyroxine | 2022 |
[Non-autoimmune thyroiditis].
Topics: Amiodarone; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Diagnosis, Differential; Gluco | 2014 |
Thyrotoxicosis.
Topics: Agranulocytosis; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Autoimmune Diseases; Child; Ex | 2012 |
Inflammatory thyroid disorders.
Topics: Amiodarone; Humans; Thyroiditis; Treatment Outcome | 2003 |
[Amiodarone and the thyroid gland].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Glucocorticoids; Humans; Hy | 2004 |
1 trial available for amiodarone and Thyroiditis
| Article | Year |
|---|---|
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Female; Follow-U | 2007 |
16 other studies available for amiodarone and Thyroiditis
| Article | Year |
|---|---|
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis.
Topics: Amiodarone; COVID-19; Genome, Viral; Humans; Hyperthyroidism; SARS-CoV-2; Thyroidectomy; Thyroiditis | 2022 |
Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cell Line; DNA-Binding Proteins; Down-Regulation; Endoplasmic Re | 2015 |
Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antith | 2009 |
Images in endocrine pathology: thyrotoxicosis associated with destructive thyroiditis.
Topics: Amiodarone; Heart Diseases; Humans; Male; Middle Aged; Thyroidectomy; Thyroiditis; Thyrotoxicosis; T | 2012 |
The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; C-Reactive Protein; Case-Control Studie | 2003 |
Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Topics: Adult; Aged; Amiodarone; Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Female; Glucoco | 2005 |
[Sonography of the thyroid--part 2: thyroid inflammation, impairmant of thyroid function and interventions].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Female; Humans; Hyperthyroidism; | 2008 |
Thyroid iodine content measured by x-ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication.
Topics: Amiodarone; Diagnosis, Differential; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroid | 1983 |
Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
Topics: Adult; Aged; Amiodarone; Biopsy; Female; Humans; Hypothyroidism; Male; Middle Aged; Thyroiditis; Thy | 1993 |
Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antithyroid Agents; Fatal Outcome; Hum | 1996 |
Influence of age on optimal daily levothyroxine dosage in patients with primary hypothyroidism grouped according to etiology.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amiodarone; Anti-Arrhythmia Agents; Antimanic Agents; Female; | 1997 |
Clinical picture: amiodarone-induced thyroiditis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Middle Aged; Thyroiditis; Ultrasonography | 2002 |
Amiodarone-induced thyroiditis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Iodine; Thyroid Gland; Thyroiditis | 2002 |
Amiodarone-induced thyroiditis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Radionuclide Imaging; Thyroid Function Tests; Thyroid Gl | 2002 |
Hyperthyroidism with a low iodine uptake.
Topics: Amiodarone; Humans; Hyperthyroidism; Iatrogenic Disease; Iodine; Iodine Radioisotopes; Radionuclide | 1985 |
Amiodarone-induced thyroiditis.
Topics: Aged; Amiodarone; Female; Humans; Thyroiditis | 1989 |